Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.91 Billion
CN¥14.05 Billion CNY
Market Cap Rank
#6553 Global
#1010 in China
Share Price
CN¥15.69
Change (1 day)
-1.38%
52-Week Range
CN¥13.75 - CN¥19.38
All Time High
CN¥106.29
Categories
Companies in China Medical Instruments & Supplies
About

Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic … Read more

Autek China Inc (300595) - Net Assets

Latest net assets as of September 2025: CN¥5.43 Billion CNY

Based on the latest financial reports, Autek China Inc (300595) has net assets worth CN¥5.43 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥6.42 Billion) and total liabilities (CN¥994.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥5.43 Billion
% of Total Assets 84.52%
Annual Growth Rate 38.28%
5-Year Change 158.32%
10-Year Change 1928.78%
Growth Volatility 39.08

Autek China Inc - Net Assets Trend (2012–2024)

This chart illustrates how Autek China Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Autek China Inc (2012–2024)

The table below shows the annual net assets of Autek China Inc from 2012 to 2024.

Year Net Assets Change
2024-12-31 CN¥5.14 Billion +9.18%
2023-12-31 CN¥4.71 Billion +2.51%
2022-12-31 CN¥4.60 Billion +81.20%
2021-12-31 CN¥2.54 Billion +27.36%
2020-12-31 CN¥1.99 Billion +38.48%
2019-12-31 CN¥1.44 Billion +32.83%
2018-12-31 CN¥1.08 Billion +33.25%
2017-12-31 CN¥812.34 Million +157.12%
2016-12-31 CN¥315.94 Million +24.61%
2015-12-31 CN¥253.53 Million +31.99%
2014-12-31 CN¥192.08 Million +31.69%
2013-12-31 CN¥145.86 Million +38.59%
2012-12-31 CN¥105.24 Million --

Equity Component Analysis

This analysis shows how different components contribute to Autek China Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6529.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥2.40 Billion 51.03%
Common Stock CN¥896.15 Million 19.08%
Other Components CN¥1.40 Billion 29.89%
Total Equity CN¥4.70 Billion 100.00%

Autek China Inc Competitors by Market Cap

The table below lists competitors of Autek China Inc ranked by their market capitalization.

Company Market Cap
Guangzhou Goaland Energy Conservation Tech Co Ltd
SHE:300499
 		$1.21 Billion
LPI Capital Bhd
KLSE:8621
 		$1.21 Billion
CLARIVATE PLC
NYSE:CLVT
 		$1.21 Billion
Seaboard Corporation
NYSE MKT:SEB
 		$1.21 Billion
CESC Limited
NSE:CESC
 		$1.21 Billion
Scatec ASA
PINK:STECF
 		$1.21 Billion
Shurgard Self Storage S.A
PINK:SSSAF
 		$1.21 Billion
Dongguan Eontec Co Ltd
SHE:300328
 		$1.21 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Autek China Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,351,396,055 to 4,697,006,548, a change of 345,610,493 (7.9%).
  • Net income of 572,230,430 contributed positively to equity growth.
  • Dividend payments of 203,348,713 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥572.23 Million +12.18%
Dividends Paid CN¥203.35 Million -4.33%
Other Changes CN¥-23.27 Million -0.5%
Total Change CN¥- 7.94%

Book Value vs Market Value Analysis

This analysis compares Autek China Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.00x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 94.28x to 3.00x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 CN¥0.17 CN¥15.69 x
2013-12-31 CN¥0.23 CN¥15.69 x
2014-12-31 CN¥0.30 CN¥15.69 x
2015-12-31 CN¥0.40 CN¥15.69 x
2016-12-31 CN¥0.49 CN¥15.69 x
2017-12-31 CN¥0.96 CN¥15.69 x
2018-12-31 CN¥1.21 CN¥15.69 x
2019-12-31 CN¥1.57 CN¥15.69 x
2020-12-31 CN¥2.06 CN¥15.69 x
2021-12-31 CN¥2.61 CN¥15.69 x
2022-12-31 CN¥4.86 CN¥15.69 x
2023-12-31 CN¥4.87 CN¥15.69 x
2024-12-31 CN¥5.24 CN¥15.69 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Autek China Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.18%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 31.55%
  • • Asset Turnover: 0.30x
  • • Equity Multiplier: 1.28x
  • Recent ROE (12.18%) is below the historical average (23.52%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 28.59% 43.99% 0.59x 1.10x CN¥19.56 Million
2013 17.00% 27.25% 0.56x 1.12x CN¥10.21 Million
2014 33.45% 49.10% 0.62x 1.10x CN¥44.71 Million
2015 35.14% 50.33% 0.59x 1.18x CN¥63.46 Million
2016 36.61% 48.52% 0.66x 1.15x CN¥82.89 Million
2017 18.74% 48.41% 0.34x 1.15x CN¥70.36 Million
2018 21.12% 47.17% 0.37x 1.20x CN¥113.85 Million
2019 23.07% 47.44% 0.40x 1.21x CN¥173.85 Million
2020 24.73% 49.77% 0.39x 1.26x CN¥258.12 Million
2021 25.04% 42.84% 0.44x 1.34x CN¥333.15 Million
2022 14.75% 40.90% 0.30x 1.21x CN¥200.83 Million
2023 15.32% 38.37% 0.31x 1.27x CN¥231.46 Million
2024 12.18% 31.55% 0.30x 1.28x CN¥102.53 Million

Industry Comparison

This section compares Autek China Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,484,451,487
  • Average return on equity (ROE) among peers: 10.47%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Autek China Inc (300595) CN¥5.43 Billion 28.59% 0.18x $1.21 Billion
Beijing Centergate Technologies Holding Co Ltd (000931) $2.03 Billion -9.26% 2.64x $356.80 Million
Blue Sail Medical Co Ltd (002382) $10.54 Billion 10.97% 0.61x $763.05 Million
Andon Health Co Ltd (002432) $758.75 Million 1.34% 0.32x $2.12 Billion
Allmed Medical Products Co Ltd Class A (002950) $2.75 Billion 15.67% 0.82x $346.13 Million
Guangzhou Improve Med Instrument (300030) $592.55 Million 4.90% 0.10x $234.74 Million
Shanghai Tofflon Science Tech (300171) $2.41 Billion 11.06% 0.57x $784.88 Million
Truking Technology Ltd (300358) $320.32 Million 29.77% 1.35x $545.42 Million
Jiangxi Sanxin Medtec Co Ltd (300453) $1.41 Billion 16.14% 0.58x $438.45 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573) $1.55 Billion 13.64% 0.15x $1.62 Billion